The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019
Open accessAbstract
Precision medicine is a patient-specific approach that integrates all relevant clinical, genetic and biological information in order to optimise the therapeutic benefit relative to the possibility of side-effects for each individual. Recent clinical trials have shown that higher blood eosinophil counts are associated with a greater efficacy of inhaled corticosteroids (ICSs) in chronic obstructive pulmonary disease (COPD) patients. Blood eosinophil counts are a biomarker with potential to be used in clinical practice, to help target ICS treatment with more precision in COPD patients with a history of exacerbations despite appropriate bronchodilator treatment. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 pharmacological treatment algorithms, based on the ABCD assessment, can be applied relatively easily to treatment-naive individuals at initial presentation. However, their use is more problematic during follow-up in patients who are already on maintenance treatment. There is a need for a different system to guide COPD pharmacological management during follow-up. Recent large randomised controlled trials have provided important new information concerning the therapeutic effects of ICSs and long-acting bronchodilators on exacerbations. The new evidence regarding blood eosinophils and inhaled treatments, and the need to distinguish between initial and follow-up pharmacological management, led to changes in the GOLD pharmacological treatment recommendations. This article explains the evidence and rationale for the GOLD 2019 pharmacological treatment recommendations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self-citationGlobal Initiative for Chronic Obstructive Lung Disease
Gerald, L. B., & Bailey, W. C. (2002) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200207000-00004 · Cited by 5,830
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925 · cited 1×
“Individualization of COPD pharmacological treatment has progressed significantly since the days of FEV1 guided pharmacological management(47).”
BackgroundSelf-citationVogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0218pp · Cited by 3,187
Self-citationOnce-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
Lipson, D. A., Barnhart, F., Brealey, N., Brooks, J., Criner, G. J., Day, N. C., Dransfield, M. T., Halpin, D. M. G., Han, M. K., Jones, C. E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1713901 · Cited by 1,253
Self-citationAzithromycin for prevention of exacerbations of COPD
Albert, R. K., Connett, J., Bailey, W. C., Casaburi, R., Cooper, J. A. D., Criner, G. J., Curtis, J. L., Dransfield, M. T., Han, M. K., Lazarus, S. C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104623 · Cited by 1,226
Self-citationIndacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD
Wedzicha, J. A., Banerji, D., Chapman, K. R., Vestbo, J., Roche, N., Ayers, R. T., Thach, C., Fogel, R., Patalano, F., & Vogelmeier, C. F. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516385 · Cited by 844
Self-citationPascoe, S., Locantore, N., Dransfield, M. T., Barnes, N. C., & Pavord, I. D. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00106-x · Cited by 743
Self-citationBafadhel, M., McKenna, S., Terry, S., Mistry, V., Pancholi, M., Venge, P., Lomas, D. A., Barer, M. R., Johnston, S. L., Pavord, I. D., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201108-1553oc · Cited by 612
Self-citationPapi, A., Vestbo, J., Fabbri, L., Corradi, M., Prunier, H., Cohuet, G., Guasconi, A., Montagna, I., Vezzoli, S., Petruzzelli, S., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30206-x · Cited by 603
Self-citationBrightling, C. E., Monteiro, W., Ward, R., Parker, D., Morgan, M. D., Wardlaw, A. J., & Pavord, I. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02872-5 · Cited by 595
Self-citationEosinophilic inflammation in COPD: prevalence and clinical characteristics
Singh, D., Kolsum, U., Brightling, C. E., Locantore, N., Agusti, A., & Tal-Singer, R. (2014) · European Respiratory Journal · doi:10.1183/09031936.00162414 · Cited by 497
Self-citationBafadhel, M., Peterson, S., De Blas, M. A., Calverley, P. M., Rennard, S. I., Richter, K., & Fagerås, M. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30006-7 · Cited by 442
Vedel-Krogh, S., Nielsen, S. F., Lange, P., Vestbo, J., & Nordestgaard, B. G. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201509-1869oc · Cited by 431
Self-citationVestbo, J., Papi, A., Corradi, M., Blazhko, V., Montagna, I., Francisco, C., Cohuet, G., Vezzoli, S., Scuri, M., & Singh, D. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30188-5 · Cited by 425
Self-citationSiddiqui, S. H., Guasconi, A., Vestbo, J., Jones, P., Agusti, A., Paggiaro, P., Wedzicha, J. A., & Singh, D. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201502-0235le · Cited by 415
Self-citationMartinez, F. J., Calverley, P. M. A., Goehring, U.-M., Brose, M., Fabbri, L. M., & Rabe, K. F. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62410-7 · Cited by 374
Self-citationBrightling, C. E. (2005) · Thorax · doi:10.1136/thx.2004.032516 · Cited by 369
Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
Pavord, I. D., Lettis, S., Locantore, N., Pascoe, S., Jones, P. W., Wedzicha, J. A., & Barnes, N. C. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207021 · Cited by 327
Self-citationChapman, K. R., Hurst, J. R., Frent, S.-M., Larbig, M., Fogel, R., Guerin, T., Banerji, D., Patalano, F., Goyal, P., Pfister, P., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201803-0405oc · Cited by 251
Self-citationYun, J. H., Lamb, A., Chase, R., Singh, D., Parker, M. M., Saferali, A., Vestbo, J., Tal-Singer, R., Castaldi, P. J., Silverman, E. K., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.04.010 · Cited by 249
Self-citationWoodruff, P. G., Agusti, A., Roche, N., Singh, D., & Martinez, F. J. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60693-6 · Cited by 241
Self-citationInhaled corticosteroids in COPD: friend or foe?
Agusti, A., Fabbri, L. M., Singh, D., Vestbo, J., Celli, B., Franssen, F. M. E., Rabe, K. F., & Papi, A. (2018) · European Respiratory Journal · doi:10.1183/13993003.01219-2018 · Cited by 229
Self-citationPrecision medicine in airway diseases: moving to clinical practice
Agustí, A., Bafadhel, M., Beasley, R., Bel, E. H., Faner, R., Gibson, P. G., Louis, R., McDonald, V. M., Sterk, P. J., Thomas, M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.01655-2017 · Cited by 215
Self-citationEosinophils in COPD: just another biomarker?
Bafadhel, M., Pavord, I. D., & Russell, R. E. K. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30217-5 · Cited by 211
Self-citationCalverley, P. M. A., Anzueto, A. R., Carter, K., Grönke, L., Hallmann, C., Jenkins, C., Wedzicha, J., & Rabe, K. F. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30102-4 · Cited by 189
Self-citationPavord, I. D., Lettis, S., Anzueto, A., & Barnes, N. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30148-5 · Cited by 184
Self-citationPrevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD
Casanova, C., Celli, B. R., de-Torres, J. P., Martínez-Gonzalez, C., Cosio, B. G., Pinto-Plata, V., de Lucas-Ramos, P., Divo, M., Fuster, A., Peces-Barba, G., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.01162-2017 · Cited by 181
Self-citationTiotropium + olodaterol shows clinically meaningful improvements in quality of life
Singh, D., Ferguson, G. T., Bolitschek, J., Grönke, L., Hallmann, C., Bennett, N., Abrahams, R., Schmidt, O., & Bjermer, L. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.08.002 · Cited by 175
Self-citationDual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study
Mahler, D. A., Decramer, M., D'Urzo, A., Worth, H., White, T., Alagappan, V. K. T., Chen, H., Gallagher, N., Kulich, K., & Banerji, D. (2014) · European Respiratory Journal · doi:10.1183/09031936.00124013 · Cited by 163
Blood and sputum eosinophils in COPD; relationship with bacterial load
Kolsum, U., Donaldson, G. C., Singh, R., Barker, B. L., Gupta, V., George, L., Webb, A. J., Thurston, S., Brookes, A. J., McHugh, T. D., et al. (2017) · Respiratory Research · doi:10.1186/s12931-017-0570-5 · Cited by 144
Self-citationOshagbemi, O. A., Burden, A. M., Braeken, D. C. W., Henskens, Y., Wouters, E. F. �., Driessen, J. H. M., der Zee, A. H. M., de Vries, F., & Franssen, F. M. E. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0009le · Cited by 136
Eosinophilia, Frequent Exacerbations, and Steroid Response in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Tetzlaff, K., Vogelmeier, C. F., Fabbri, L. M., MAGNUSSEN, H., Wouters, E. F. �., Mezzanotte, W. S., Disse, B. G., Finnigan, H., Asijee, G. M., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201612-2525le · Cited by 122
Self-citationKolsum, U., Damera, G., Pham, T., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.04.027 · Cited by 114
Brightling, C. E., Monterio, W., GREEN, R. H., Parker, D., Morgan, M. D. L., Wardlaw, A. J., & Pavord, I. D. (2001) · Respiratory Medicine · doi:10.1053/rmed.2001.1195 · Cited by 109
Self-citationSuissa, S., Dell’Aniello, S., & Ernst, P. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30368-0 · Cited by 106
Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease
Singh, D., Roche, N., Halpin, D. M. G., Agustí, A. G. N., Wedzicha, J. A., & Martínez, F. J. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201606-1179pp · Cited by 82
Self-citationThe reproducibility of COPD blood eosinophil counts
Southworth, T. W., Beech, G., Foden, P., Kolsum, U., & Singh, D. (2018) · European Respiratory Journal · doi:10.1183/13993003.00427-2018 · Cited by 76
Self-citationLandis, S., Suruki, R., Hilton, E., Compton, C. H., & Galwey, N. W. (2017) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2017.1313827 · Cited by 70
Landis, S., Suruki, R., Maskell, J., Bonar, K., Hilton, E., & Compton, C. H. (2018) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2018.1441275 · Cited by 41
Repeatability of Inflammatory Parameters in Induced Sputum of COPD Patients
Boorsma, M., Lutter, R., van de Pol, M. A., Out, T. A., Jansen, H. M., & Jonkers, R. E. (2007) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550701597720 · Cited by 34
Pharmacological treatment of COPD: the devil is always in the detail
Singh, D., Barnes, P. J., Stockley, R. A., Valera, M. V. L., Vogelmeier, C. F., & Agustí, A. G. N. (2018) · European Respiratory Journal · doi:10.1183/13993003.00263-2018 · Cited by 22
Self-citationFaner, R., Noell, G. G., Badia, J. R., López-Giraldo, A., Bakke, P. S., Silverman, E. K., Tal‐Singer, R., & Agustí, A. G. N. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.06.015 · Cited by 16
Cited by
ERS/ATS technical standard on interpretive strategies for routine lung function tests
Stanojevic, S., Kaminsky, D. A., Miller, M. R., Thompson, B., Aliverti, A., Barjaktarevic, I., Cooper, B. G., Culver, B., Derom, E., Hall, G. L., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.01499-2021 · Cited by 1,656
Bai, J., Zhang, Y., Tang, C., Hou, Y., Ai, X., Chen, X., Zhang, Y., Wang, X., & Meng, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110985 · Cited by 720
Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission
Stolz, D., Mkorombindo, T., Schumann, D. M., Agusti, A., Ash, S. Y., Bafadhel, M., Bai, C., Chalmers, J. D., Criner, G. J., Dharmage, S. C., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01273-9 · Cited by 681
Self-citationRespiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis
Torres-Castro, R., Vasconcello-Castillo, L., Alsina-Restoy, X., Solis-Navarro, L., Burgos, F., Puppo, H., & Vilaró, J. (2021) · Pulmonology · doi:10.1016/j.pulmoe.2020.10.013 · Cited by 540
Chen, S., Kuhn, M., Prettner, K., Yu, F., Yang, T., Bärnighausen, T., Bloom, D. E., & Wang, C. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00217-6 · Cited by 487
Metadata
- Authors
- Singh, D., Agusti, A., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Criner, G. J., Frith, P., Halpin, D. M. G., Han, M., López Varela, M. V., Martinez, F., Montes de Oca, M., Papi, A., Pavord, I. D., Roche, N., Sin, D. D., Stockley, R., Vestbo, J., Wedzicha, J. A., & Vogelmeier, C.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-03-07
- Volume
- 53
- Issue
- 5
- Pages
- 1900164
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2920797638
- Cited by
- 1,937
- References
- 43
- FWCI
- 191.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.